
Company valuation, historical trends, and peer comparisons.
According to Goldenwell Biotech, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 64.65M. This represents a change of -43.47% compared to the average of 114.36M of the last 4 quarters.
The mean historical Enterprise Value of Goldenwell Biotech, Inc. over the last ten years is 59.75M. The current 64.65M Enterprise Value has changed 8.20% with respect to the historical average. Over the past ten years (40 quarters), GWLL's Enterprise Value was at its highest in in the December 2025 quarter at 287.07M. The Enterprise Value was at its lowest in in the December 2023 quarter at 5.60M.
Average
59.75M
Median
26.77M
Minimum
5.74M
Maximum
287.17M
Discovering the peaks and valleys of Goldenwell Biotech, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.35%
Maximum Annual Enterprise Value = 287.17M
Minimum Annual Increase = -79.81%
Minimum Annual Enterprise Value = 5.74M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 287.17M | 1.35% |
| 2024 | 19.85M | 245.77% |
| 2023 | 5.74M | -79.81% |
| 2022 | 28.43M | 6.17% |
| 2021 | 26.77M | -4.62% |
| 2020 | 28.07M | 26.28% |
The current Enterprise Value of Goldenwell Biotech, Inc. (GWLL) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
104.25M
5-year avg
73.59M
10-year avg
59.75M
Goldenwell Biotech, Inc.’s Enterprise Value is greater than Bio Essence Corporation (18.99M), greater than BioAdaptives Inc. (788.89K), greater than DSwiss, Inc. (16.54M), greater than Health Sciences Group, Inc. (2.37M), less than LifeVantage Corporation (68.85M), greater than Reliv' International, Inc. (1.80M), greater than NuVim, Inc. (688.34K),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 18.99M | $17.42M | |
| 788.89K | $295.39K | |
| 16.54M | $16.55M | |
| 2.37M | $2.05M | |
| 68.85M | $73.90M | |
| 1.80M | $2.86M | |
| 688.34K | $655.13K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Goldenwell Biotech, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Goldenwell Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Goldenwell Biotech, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Goldenwell Biotech, Inc. (GWLL)?
What is the 3-year average Enterprise Value for Goldenwell Biotech, Inc. (GWLL)?
What is the 5-year average Enterprise Value for Goldenwell Biotech, Inc. (GWLL)?
How does the current Enterprise Value for Goldenwell Biotech, Inc. (GWLL) compare to its historical average?